Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A US health panel advises starting mammograms at age 40 rather than 50.

2.

TULSA Is Effective in Long-Term Prostate Cancer Control.

3.

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

4.

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

5.

How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot